Vitamin D, childhood wheezing, asthma, and chronic obstructive pulmonary Disease

Vitamin D

Volumn , Issue , 2011, Pages 1999-2021

  Camargo, Carlos A ^a   Ginde, Adit A ^b   Mansbach, Jonathan M ^c  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^c BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84861537904     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-381978-9.10103-9     Document Type: Chapter

References (205)

1. Lawrence G. Tools of the trade: the Finsen Light. Lancet 2002, 359:1784.
2. Hobday R.A. Sunlight therapy and solar architecture. Med. Hist. 1997, 41:455-472.
3. Cannell J.J., Vieth R., Umhau J.C., Holick M.F., Grant W.B., Madronich S., et al. Epidemic influenza and vitamin D. Epidemiol. Infect. 2006, 134:1129-1140.
4. Zasloff M. Fighting infections with vitamin D. Nat. Med. 2006, 12:388-390.
5. Adams J.S., Hewison M. Unexpected actions of vitamin D: new perspectives on the regulation of innate and adaptive immunity. Nat. Clin. Pract. Endocrinol. Metab. 2008, 4:80-90.
6. Gombart A.F. The vitamin D-antimicrobial peptide pathway and its role in protection against infection. Future Microbiol. 2009, 4:1151-1165.
7. Yamshchikov A.V., Desai N.S., Blumberg H.M., Ziegler T.R., Tangpricha V. Vitamin D for treatment and prevention of infectious diseases: a systematic review of randomized controlled trials. Endocr. Pract. 2009, 15:438-449.
8. Chesney R.W. Vitamin D and The Magic Mountain: the anti-infectious role of the vitamin. J. Pediatr. 2010, 156:698-703.
9. Beser E., Cakmakci T. Factors affecting the morbidity of vitamin D deficiency rickets and primary protection. East Afr. Med. J. 1994, 71:358-362.
10. Muhe L., Lulseged S., Mason K.E., Simoes E.A. Case-control study of the role of nutritional rickets in the risk of developing pneumonia in Ethiopian children. Lancet 1997, 349:1801-1804.
11. Najada A.S., Habashneh M.S., Khader M. The frequency of nutritional rickets among hospitalized infants and its relation to respiratory diseases. J. Trop. Pediatr. 2004, 50:364-368.
12. Laaksi I., Ruohola J.P., Tuohimaa P., Auvinen A., Haataja R., Pihlajamaki H., et al. An association of serum vitamin D concentrations <40nmol/L with acute respiratory tract infection in young Finnish men. Am. J. Clin. Nutr. 2007, 86:714-717.
13. Camargo C.A., Ingham T., Wickens K., Thadhani R., Silvers K., Epton M., et al. Cord blood 25-hydroxyvitamin D levels and risk of childhood wheeze in New Zealand [abstract]. Am. J. Respir. Crit. Care Med. 2008, 177(Suppl.):A993.
14. Ginde A.A., Mansbach J.M., Camargo C.A. Association between serum 25-hydroxyvitamin D level and upper respiratory tract infection in the Third National Health and Nutrition Examination Survey. Arch. Intern. Med. 2009, 169:384-390.
15. White A.N., Ng V., Spain C.V., Johnson C.C., Kinlin L.M., Fisman D.N. Let the sun shine in: effects of ultraviolet radiation on invasive pneumococcal disease risk in Philadelphia, Pennsylvania. BMC Infect. Dis. 2009, 9:196.
16. Sabetta J.R., DePetrillo P., Cipriani R.J., Smardin J., Burns L.A., Landry M.L. Serum 25-hydroxyvitamin D and the incidence of acute viral respiratory tract infections in healthy adults. PLoS One 2010, 5:e11088.
17. Wjst M., Dold S. Genes, factor X, and allergens: what causes allergic diseases?. Allergy 1999, 54:757-759.
18. Poon A.H., Laprise C., Lemire M., Montpetit A., Sinnett D., Schurr E., et al. Association of vitamin D receptor genetic variants with susceptibility to asthma and atopy. Am. J. Respir. Crit. Care Med. 2004, 170:967-973.
19. Raby B.A., Lazarus R., Silverman E.K., Lake S., Lange C., Wjst M., et al. Association of vitamin D receptor gene polymorphisms with childhood and adult asthma. Am. J. Respir. Crit. Care Med. 2004, 170:1057-1065.
20. Vollmert C., Illig T., Altmuller J., Klugbauer S., Loesgen S., Dumitrescu L., et al. Single nucleotide polymorphism screening and association analysis - exclusion of integrin beta 7 and vitamin D receptor (chromosome 12q) as candidate genes for asthma. Clin. Exp. Allergy 2004, 34:1841-1850.
21. Laufs J., Andrason H., Sigvaldason A., Halapi E., Thorsteinsson L., Jonasson K., et al. Association of vitamin D binding protein variants with chronic mucus hypersecretion in Iceland. Am. J. Pharmacogenomics 2004, 4:63-68.
22. Wjst M. Variants in the vitamin D receptor gene and asthma. BMC Genet. 2005, 6:2.
23. Camargo C.A., Rifas-Shiman S.L., Litonjua A.A., Rich-Edwards J.W., Weiss S.T., Gold D.R., et al. Prospective study of maternal intake of vitamin D during pregnancy and risk of wheezing illnesses in children at age 2 years [abstract]. J. Allergy Clin. Immunol. 2006, 117:721-722.
24. Martinez F.D., Wright A.L., Taussig L.M., Holberg C.J., Halonen M., Morgan W.J. Asthma and wheezing in the first six years of life. The Group Health Medical Associates. N. Engl. J. Med. 1995, 332:133-138.
25. Hahn E.L., Bacharier L.B. The atopic march: the pattern of allergic disease development in childhood. Immunol. Allergy Clin. North Am. 2005, 25:231-246. v.
26. Ker J., Hartert T.V. The atopic march: what's the evidence?. Ann. Allergy. Asthma. Immunol. 2009, 103:282-289.
27. Graham N.M. The epidemiology of acute respiratory infections in children and adults: a global perspective. Epidemiol. Rev. 1990, 12:149-178.
28. Taubenberger J.K., Morens D.M. 1918 Influenza: the mother of all pandemics. Emerg. Infect. Dis. 2006, 12:15-22.
29. Mansbach J.M., Camargo C.A. Update on bronchiolitis. Emerg. Med. Crit. Care Rev. 2008, 4:35-38.
30. Pelletier A.J., Mansbach J.M., Camargo C.A. Direct medical costs of bronchiolitis hospitalizations in the United States. Pediatrics 2006, 118:2418-2423.
31. Fleisher G.R. Infectious disease emergencies. Textbook of Pediatric Emergency Medicine 2000, 754-755. Lippincott William & Wilkins, Philadelphia. fourth ed. G.R. Fleisher, S. Ludwig (Eds.).
32. Hanson I.C., Shearer W.T. Bronchiolitis. Oski's Pediatrics: Principles and Practice 1999, 1214-1216. Lippincott Williams & Wilkins, Philadelphia. third ed. J.A. McMillan, C.D. DeAngelis, R.D. Feigin, J.B. Warshaw (Eds.).
33. Welliver R. Bronchiolitis and infectious asthma. Textbook of Pediatric Infectious Diseases 2004, 273-285. Saunders, Philadelphia. fifth ed. R. Feigin, J. Cherry, G. Demmler, S. Kaplan (Eds.).
34. Mansbach J.M., Espinola J.A., Macias C.G., Ruhlen M.E., Sullivan A.F., Camargo C.A. Variability in the diagnostic labeling of nonbacterial lower respiratory tract infections: a multicenter study of children who presented to the emergency department. Pediatrics 2009, 123:e573-581.
35. American Academy of Pediatrics Diagnosis and management of bronchiolitis. Pediatrics 2006, 118:1774-1793.
36. Glezen W.P., Taber L.H., Frank A.L., Kasel J.A. Risk of primary infection and reinfection with respiratory syncytial virus. Am. J. Dis. Child 1986, 140:543-546.
37. Ukkonen P., Hovi T., von Bonsdorff C.H., Saikku P., Penttinen K. Age-specific prevalence of complement-fixing antibodies to sixteen viral antigens: a computer analysis of 58,500 patients covering a period of eight years. J. Med. Virol. 1984, 13:131-148.
38. Glezen W.P., Loda F.A., Clyde W.A., Senior R.J., Sheaffer C.I., Conley W.G., et al. Epidemiologic patterns of acute lower respiratory disease of children in a pediatric group practice. J. Pediatr. 1971, 78:397-406.
39. Hall C.B., Walsh E.E., Schnabel K.C., Long C.E., McConnochie K.M., Hildreth S.W., et al. Occurrence of groups A and B of respiratory syncytial virus over 15 years: associated epidemiologic and clinical characteristics in hospitalized and ambulatory children. J. Infect. Dis. 1990, 162:1283-1290.
40. Levine D.A., Platt S.L., Dayan P.S., Macias C.G., Zorc J.J., Krief W., et al. Risk of serious bacterial infection in young febrile infants with respiratory syncytial virus infections. Pediatrics 2004, 113:1728-1734.
41. Mansbach J.M., Emond J.A., Camargo C.A. Bronchiolitis in US emergency departments 1992 to 2000: epidemiology and practice variation. Pediatr. Emerg. Care 2005, 21:242-247.
42. Mansbach J.M., Clark S., Christopher N.C., LoVecchio F., Kunz S., Acholonu U., et al. Prospective multicenter study of bronchiolitis: predicting safe discharges from the emergency department. Pediatrics 2008, 121:680-688.
43. Papadopoulos N.G., Bates P.J., Bardin P.G., Papi A., Leir S.H., Fraenkel D.J., et al. Rhinoviruses infect the lower airways. J. Infect. Dis. 2000, 181:1875-1884.
44. Korppi M., Kotaniemi-Syrjanen A., Waris M., Vainionpaa R., Reijonen T.M. Rhinovirus-associated wheezing in infancy: comparison with respiratory syncytial virus bronchiolitis. Pediatr. Infect. Dis. J. 2004, 23:995-999.
45. Henderson F.W., Clyde W.A., Collier A.M., Denny F.W., Senior R.J., Sheaffer C.I., et al. The etiologic and epidemiologic spectrum of bronchiolitis in pediatric practice. J. Pediatr. 1979, 95:183-190.
46. Holleman D.R., Simel D.L. Does the clinical examination predict airflow limitation?. JAMA 1995, 273:313-319.
47. Weinberger M., Abu-Hasan M. Pseudo-asthma: when cough, wheezing, and dyspnea are not asthma. Pediatrics 2007, 120:855-864.
48. Peters S.P. Special considerations in adults for diagnoses that may coexist with or masquerade as asthma. Ann. Allergy Asthma. Immunol. 2010, 104:455-460.
49. Stein R.T., Martinez F.D. Asthma phenotypes in childhood: lessons from an epidemiological approach. Paediatr. Respir. Rev. 2004, 5:155-161.
50. Abouzgheib W., Pratter M.R., Bartter T. Cough and asthma. Curr. Opin. Pulm. Med. 2007, 13:44-48.
51. Heikkinen T., Jarvinen A. The common cold. Lancet 2003, 361:51-59.
52. Moorman J.E., Rudd R.A., Johnson C.A., King M., Minor P., Bailey C., et al. National surveillance for asthma - United States, 1980-2004. MMWR. Surveill. Summ. 2007, 56:1-54.
53. Ginde A.A., Espinola J.A., Camargo C.A. Improved overall trends but persistent racial disparities in emergency department visits for acute asthma, 1993-2005. J. Allergy Clin. Immunol. 2008, 122:313-318.
54. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. Am. Rev. Respir. Dis. 1987, 136:225-244. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, November 1986.
55. Toren K., Brisman J., Jarvholm B. Asthma and asthma-like symptoms in adults assessed by questionnaires. A literature review. Chest 1993, 104:600-608.
56. Nicholson K.G., Kent J., Ireland D.C. Respiratory viruses and exacerbations of asthma in adults. BMJ 1993, 307:982-986.
57. Johnston S.L., Pattemore P.K., Sanderson G., Smith S., Lampe F., Josephs L., et al. Community study of role of viral infections in exacerbations of asthma in 9-11 year old children. BMJ 1995, 310:1225-1229.
58. Yunginger J.W., Reed C.E., O'Connell E.J., Melton L.J., O'Fallon W.M., Silverstein M.D. A community-based study of the epidemiology of asthma. Incidence rates, 1964-1983. Am. Rev. Respir. Dis. 1992, 146:888-894.
59. Wainwright C., Isles A.F., Francis P.W. Asthma in children. Med. J. Aust. 1997, 167:218-223.
60. Kumar R. Prenatal factors and the development of asthma. Curr. Opin. Pediatr. 2008, 20:682-687.
61. Guilbert T.W., Morgan W.J., Zeiger R.S., Bacharier L.B., Boehmer S.J., Krawiec M., et al. Atopic characteristics of children with recurrent wheezing at high risk for the development of childhood asthma. J. Allergy. Clin. Immunol. 2004, 114:1282-1287.
62. Arbes S.J., Gergen P.J., Vaughn B., Zeldin D.C. Asthma cases attributable to atopy: results from the Third National Health and Nutrition Examination Survey. J. Allergy Clin. Immunol. 2007, 120:1139-1145.
63. Borish L., Culp J.A. Asthma: a syndrome composed of heterogeneous diseases. Ann. Allergy Asthma Immunol. 2008, 101:1-8. quiz 8-11, 50.
64. Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2009 Global strategy for the diagnosis, management, and prevention of COPD. Available at: . Last accessed: 8/1/2010. http://www.goldcopd.com/.
65. Nnoaham K.E., Clarke A. Low serum vitamin D levels and tuberculosis: a systematic review and meta-analysis. Int. J. Epidemiol. 2008, 37:113-119.
66. Martineau A.R., Honecker F.U., Wilkinson R.J., Griffiths C.J. Vitamin D in the treatment of pulmonary tuberculosis. J. Steroid. Biochem. Mol. Biol. 2007, 103:793-798.
67. Wilkinson R.J., Llewelyn M., Toossi Z., Patel P., Pasvol G., Lalvani A., et al. Influence of vitamin D deficiency and vitamin D receptor polymorphisms on tuberculosis among Gujarati Asians in west London: a case-control study. Lancet 2000, 355:618-621.
68. Wilbur A.K., Kubatko L.S., Hurtado A.M., Hill K.R., Stone A.C. Vitamin D receptor gene polymorphisms and susceptibility M. tuberculosis in native Paraguayans. Tuberculosis (Edinb.) 2007, 87:329-337.
69. Martineau A.R., Leandro A.C., Anderson S.T., Newton S.M., Wilkinson K.A., Nicol M.P., et al. Association between Gc genotype and susceptibility to TB is dependent on vitamin D status. Eur. Respir. J. 2010, 35:1106-1112.
70. Martineau A.R., Wilkinson R.J., Wilkinson K.A., Newton S.M., Kampmann B., Hall B.M., et al. A single dose of vitamin D enhances immunity to mycobacteria. Am. J. Respir. Crit. Care Med. 2007, 176:208-213.
71. Wejse C., Gomes V.F., Rabna P., Gustafson P., Aaby P., Lisse I.M., et al. Vitamin D as supplementary treatment for tuberculosis: a double-blind, randomized, placebo-controlled trial. Am. J. Respir. Crit. Care Med. 2009, 179:843-850.
72. Banajeh S.M. Nutritional rickets and vitamin D deficiency - association with the outcomes of childhood very severe pneumonia: a prospective cohort study. Pediatr. Pulmonol. 2009, 44:1207-1215.
73. Lips P. Worldwide status of vitamin D nutrition. J. Steroid Biochem. Mol. Biol. 2010, 121:297-300.
74. Wayse V., Yousafzai A., Mogale K., Filteau S. Association of subclinical vitamin D deficiency with severe acute lower respiratory infection in Indian children under 5 y. Eur. J. Clin. Nutr. 2004, 58:563-567.
75. Karatekin G., Kaya A., Salihoglu O., Balci H., Nuhoglu A. Association of subclinical vitamin D deficiency in newborns with acute lower respiratory infection and their mothers. Eur. J. Clin. Nutr. 2009, 63:473-477.
76. Roth D.E., Shah R., Black R.E., Baqui A.H. Vitamin D status and acute lower respiratory infection in early childhood in Sylhet, Bangladesh. Acta Paediatr. 2010, 99:389-393.
77. Roth D.E., Jones A.B., Prosser C., Robinson J.L., Vohra S. Vitamin D status is not associated with the risk of hospitalization for acute bronchiolitis in early childhood. Eur. J. Clin. Nutr. 2009, 63:297-299.
78. McNally J.D., Leis K., Matheson L.A., Karuananyake C., Sankaran K., Rosenberg A.M. Vitamin D deficiency in young children with severe acute lower respiratory infection. Pediatr. Pulmonol. 2009, 44:981-988.
79. Camargo C.A., Rifas-Shiman S.L., Litonjua A.A., Rich-Edwards J.W., Weiss S.T., Gold D.R., et al. Maternal intake of vitamin D during pregnancy and risk of recurrent wheeze in children at 3 y of age. Am. J. Clin. Nutr. 2007, 85:788-795.
80. Camargo C.A., Ingham T., Wickens K., Thadhani R.I., Silvers K.M., Epton M.J., et al. Vitamin D status of newborns in New Zealand. Br. J. Nutr. 2010, 1-7.
81. Devereux G., Litonjua A.A., Turner S.W., Craig L.C., McNeill G., Martindale S., et al. Maternal vitamin D intake during pregnancy and early childhood wheezing. Am. J. Clin. Nutr. 2007, 85:853-859.
82. Camargo C.A., Ingham T., Wickens K., Thadhani R.I., Silvers K.M., Epton M.J., et al. Cord blood 25-hydroxyvitamin D levels and risk of respiratory infection, wheezing, and asthma. Pediatrics 2011, 127:e180-187.
83. Janssen R., Bont L., Siezen C.L., Hodemaekers H.M., Ermers M.J., Doornbos G., et al. Genetic susceptibility to respiratory syncytial virus bronchiolitis is predominantly associated with innate immune genes. J. Infect. Dis. 2007, 196:826-834.
84. Roth D.E., Jones A.B., Prosser C., Robinson J.L., Vohra S. Vitamin D receptor polymorphisms and the risk of acute lower respiratory tract infection in early childhood. J. Infect. Dis. 2008, 197:676-680.
85. Chun R.F., Lauridsen A.L., Suon L., Zella L.A., Pike J.W., Modlin R.L., et al. Vitamin D-binding protein directs monocyte responses to 25-hydroxy- and 1,25-dihydroxyvitamin D. J. Clin. Endocrinol. Metab. 2010, 95:3368-3376.
86. Linday L.A., Shindledecker R.D., Tapia-Mendoza J., Dolitsky J.N. Effect of daily cod liver oil and a multivitamin-mineral supplement with selenium on upper respiratory tract pediatric visits by young, inner-city, Latino children: randomized pediatric sites. Ann. Otol. Rhinol. Laryngol. 2004, 113:891-901.
87. Rehman P.K. Sub-clinical rickets and recurrent infection. J. Trop. Pediatr. 1994, 40:58.
88. Aloia J.F., Li-Ng M. Re: epidemic influenza and vitamin D. Epidemiol. Infect. 2007, 135:1095-1096. author reply 1097-1098.
89. Avenell A., Cook J.A., Maclennan G.S., Macpherson G.C. Vitamin D supplementation to prevent infections: a sub-study of a randomised placebo-controlled trial in older people (RECORD trial, ISRCTN 51647438). Age Ageing 2007, 36:574-577.
90. Urashima M., Segawa T., Okazaki M., Kurihara M., Wada Y., Ida H. Randomized trial of vitamin D supplementation to prevent seasonal influenza A in schoolchildren. Am. J. Clin. Nutr. 2010, 91:1255-1260.
91. Li-Ng M., Aloia J.F., Pollack S., Cunha B.A., Mikhail M., Yeh J., et al. A randomized controlled trial of vitamin D3 supplementation for the prevention of symptomatic upper respiratory tract infections. Epidemiol. Infect. 2009, 1-9.
92. Laaksi I., Ruohola J.P., Mattila V., Auvinen A., Ylikomi T., Pihlajamaki H. Vitamin D supplementation for the prevention of acute respiratory tract infection: a randomized, double-blinded trial among young Finnish men. J. Infect. Dis. 2010, 202:809-814.
93. Gern J.E., Lemanske R.F., Busse W.W. Early life origins of asthma. J. Clin Invest. 1999, 104:837-843.
94. Warner J.A., Jones C.A., Jones A.C., Warner J.O. Prenatal origins of allergic disease. J. Allergy Clin. Immunol. 2000, 105:S493-S498.
95. Gillman M.W. Developmental origins of health and disease. N. Engl. J. Med. 2005, 353:1848-1850.
96. Weiss S.T. Diet as a risk factor for asthma. Ciba. Found Symp. 1997, 206:244-257. discussion 253-247.
97. Romieu I., Trenga C. Diet and obstructive lung diseases. Epidemiol. Rev. 2001, 23:268-287.
98. Spector S.L., Surette M.E. Diet and asthma: has the role of dietary lipids been overlooked in the management of asthma?. Ann. Allergy Asthma Immunol. 2003, 90:371-377. quiz 377-378, 421.
99. Devereux G., Seaton A. Diet as a risk factor for atopy and asthma. J. Allergy Clin. Immunol. 2005, 115:1109-1117. quiz 1118.
100. Holick M.F. Vitamin D deficiency. N. Engl. J. Med. 2007, 357:266-281.
101. Black P.N., Scragg R. Relationship between serum 25-hydroxyvitamin D and pulmonary function in the third national health and nutrition examination survey. Chest 2005, 128:3792-3798.
102. Burns J.S., Dockery D.W., Neas L.M., Schwartz J., Coull B.A., Raizenne M., et al. Low dietary nutrient intakes and respiratory health in adolescents. Chest 2007, 132:238-245.
103. Wjst M. The vitamin D slant on allergy. Pediatr. Allergy Immunol. 2006, 17:477-483.
104. Wjst M. Introduction of oral vitamin D supplementation and the rise of the allergy pandemic. Allergy Asthma Clin. Immunol. 2009, 5:8.
105. Hypponen E., Sovio U., Wjst M., Patel S., Pekkanen J., Hartikainen A.L., et al. Infant vitamin D supplementation and allergic conditions in adulthood: northern Finland birth cohort 1966. Ann. NY. Acad. Sci. 2004, 1037:84-95.
106. Gale C.R., Robinson S.M., Harvey N.C., Javaid M.K., Jiang B., Martyn C.N., et al. Maternal vitamin D status during pregnancy and child outcomes. Eur. J. Clin. Nutr. 2008, 62:68-77.
107. Back O., Blomquist H.K., Hernell O., Stenberg B. Does vitamin D intake during infancy promote the development of atopic allergy?. Acta. Derm. Venereol. 2009, 89:28-32.
108. Erkkola M., Kaila M., Nwaru B.I., Kronberg-Kippila C., Ahonen S., Nevalainen J., et al. Maternal vitamin D intake during pregnancy is inversely associated with asthma and allergic rhinitis in 5-year-old children. Clin. Exp. Allergy 2009, 39:875-882.
109. Miyake Y., Sasaki S., Tanaka K., Hirota Y. Dairy food, calcium and vitamin D intake in pregnancy, and wheeze and eczema in infants. Eur. Respir. J. 2010, 35:1228-1234.
110. Freishtat R.J., Iqbal S.F., Pillai D.K., Klein C.J., Ryan L.M., Benton A.S., et al. High prevalence of vitamin D deficiency among inner-city African American youth with asthma in Washington, DC. J. Pediatr. 2010, 156:948-952.
111. Devereux G., Wilson A., Avenell A., McNeill G., Fraser W.D. A case-control study of vitamin D status and asthma in adults. Allergy 2010, 65:666-667.
112. Bosse Y., Lemire M., Poon A.H., Daley D., He J.Q., Sandford A., et al. Asthma and genes encoding components of the vitamin D pathway. Respir. Res. 2009, 10:98.
113. Fang W.L., Gao L.B., Liang W.B., Xue H., Bai P., Lv M.L., et al. Association analysis of vitamin D receptor gene polymorphisms in Chinese population with asthma. Iran. J. Allergy Asthma Immunol. 2009, 8:141-147.
114. Saadi A., Gao G., Li H., Wei C., Gong Y., Liu Q. Association study between vitamin D receptor gene polymorphisms and asthma in the Chinese Han population: a case-control study. BMC Med. Genet. 2009, 10:71.
115. Schauber J., Gallo R.L. Vitamin D deficiency and asthma: not a strong link - yet. J. Allergy. Clin. Immunol. 2008, 121:782-783. author reply 783-784.
116. Shaheen S.O. Vitamin D deficiency and the asthma epidemic. Thorax 2008, 63:293. author reply 293.
117. Jackson D.J., Gangnon R.E., Evans M.D., Roberg K.A., Anderson E.L., Pappas T.E., et al. Wheezing rhinovirus illnesses in early life predict asthma development in high-risk children. Am. J. Respir. Crit. Care Med. 2008, 178:667-672.
118. Mansbach J.M., Camargo C.A. Bronchiolitis: lingering questions about its definition and the potential role of vitamin D. Pediatrics 2008, 122:177-179.
119. Sutherland E.R. Martin RJ 2007 Asthma and atypical bacterial infection. Chest 1962-1966, 132.
120. National Asthma Education and Prevention Program Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma: Full Report 2007 2007, US Government Printing Office, Washington DC, 417 pp. NIH Publication No. 407-4051.
121. Bateman E.D., Boushey H.A., Bousquet J., Busse W.W., Clark T.J., Pauwels R.A., et al. Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma Control study. Am. J. Respir. Crit. Care Med. 2004, 170:836-844.
122. Ito K., Chung K.F., Adcock I.M. Update on glucocorticoid action and resistance. J. Allergy Clin. Immunol. 2006, 117:522-543.
123. Xystrakis E., Kusumakar S., Boswell S., Peek E., Urry Z., Richards D.F., et al. Reversing the defective induction of IL-10-secreting regulatory T cells in glucocorticoid-resistant asthma patients. J. Clin. Invest. 2006, 116:146-155.
124. Sutherland E.R., Goleva E., Jackson L.P., Stevens A.D., Leung D.Y. Vitamin D levels, lung function, and steroid response in adult asthma. Am. J. Respir. Crit. Care Med. 2010, 181:699-704.
125. Searing D.A., Zhang Y., Murphy J.R., Hauk P.J., Goleva E., Leung D.Y. Decreased serum vitamin D levels in children with asthma are associated with increased corticosteroid use. J. Allergy Clin. Immunol. 2010, 125:995-1000.
126. van Elden L.J., Sachs A.P., van Loon A.M., Haarman M., van de Vijver D.A., Kimman T.G., et al. Enhanced severity of virus associated lower respiratory tract disease in asthma patients may not be associated with delayed viral clearance and increased viral load in the upper respiratory tract. J. Clin. Virol. 2008, 41:116-121.
127. Brehm J.M., Celedon J.C., Soto-Quiros M.E., Avila L., Hunninghake G.M., Forno E., et al. Serum vitamin D levels and markers of severity of childhood asthma in Costa Rica. Am. J. Respir. Crit. Care Med. 2009, 179:765-771.
128. Brehm J.M., Schuemann B., Fuhlbrigge A.L., Hollis B.W., Strunk R.C., Zeiger R.S., et al. Serum vitamin D levels and severe asthma exacerbations in the Childhood Asthma Management Program study. J. Allergy Clin. Immunol. 2010, 126:52-58. e55.
129. Leech J.A., Dulberg C., Kellie S., Pattee L., Gay J. Relationship of lung function to severity of osteoporosis in women. Am. Rev. Respir. Dis. 1990, 141:68-71.
130. Biskobing D.M. COPD and osteoporosis. Chest 2002, 121:609-620.
131. Katsura H., Kida K. A comparison of bone mineral density in elderly female patients with COPD and bronchial asthma. Chest 2002, 122:1949-1955.
132. Jorgensen N.R., Schwarz P., Holme I., Henriksen B.M., Petersen L.J., Backer V. The prevalence of osteoporosis in patients with chronic obstructive pulmonary disease: a cross sectional study. Respir. Med. 2007, 101:177-185.
133. Kjensli A., Mowinckel P., Ryg M.S., Falch J.A. Low bone mineral density is related to severity of chronic obstructive pulmonary disease. Bone 2007, 40:493-497.
134. Ohara T., Hirai T., Muro S., Haruna A., Terada K., Kinose D., et al. Relationship between pulmonary emphysema and osteoporosis assessed by CT in patients with COPD. Chest 2008, 134:1244-1249.
135. Franco C.B., Paz-Filho G., Gomes P.E., Nascimento V.B., Kulak C.A., Boguszewski C.L., et al. Chronic obstructive pulmonary disease is associated with osteoporosis and low levels of vitamin D. Osteoporos. Int. 2009, 20:1881-1887.
136. Wright R.J. Make no bones about it: increasing epidemiologic evidence links vitamin D to pulmonary function and COPD. Chest 2005, 128:3781-3783.
137. Dobak J., Grzybowski J., Liu F.T., Landon B., Dobke M. 1,25-Dihydroxyvitamin D3 increases collagen production in dermal fibroblasts. J. Dermatol. Sci. 1994, 8:18-24.
138. Koli K., Keski-Oja J. 1Alpha,25-dihydroxyvitamin D3 and its analogues down-regulate cell invasion-associated proteases in cultured malignant cells. Cell Growth Differ 2000, 11:221-229.
139. Spurzem J.R., Rennard S.I. Pathogenesis of COPD. Semin. Respir. Crit. Care Med. 2005, 26:142-153.
140. Kunisaki K.M., Niewoehner D.E., Singh R.J., Connett J.E. Vitamin D status and longitudinal lung function decline in the Lung Health Study. Eur. Respir. J. 2011, 37:238-243.
141. Schellenberg D., Pare P.D., Weir T.D., Spinelli J.J., Walker B.A., Sandford A.J. Vitamin D binding protein variants and the risk of COPD. Am. J. Respir. Crit. Care Med. 1998, 157:957-961.
142. Ishii T., Keicho N., Teramoto S., Azuma A., Kudoh S., Fukuchi Y., et al. Association of Gc-globulin variation with susceptibility to COPD and diffuse panbronchiolitis. Eur. Respir. J. 2001, 18:753-757.
143. Ito I., Nagai S., Hoshino Y., Muro S., Hirai T., Tsukino M., et al. Risk and severity of COPD is associated with the group-specific component of serum globulin 1F allele. Chest 2004, 125:63-70.
144. Sandford A.J., Chagani T., Weir T.D., Connett J.E., Anthonisen N.R., Pare P.D. Susceptibility genes for rapid decline of lung function in the lung health study. Am. J. Respir. Crit. Care Med. 2001, 163:469-473.
145. Janssens W., Bouillon R., Claes B., Carremans C., Lehouck A., Buysschaert I., et al. Vitamin D deficiency is highly prevalent in COPD and correlates with variants in the vitamin D-binding gene. Thorax 2010, 65:215-220.
146. Gern J.E., Rosenthal L.A., Sorkness R.L., Lemanske R.F. Effects of viral respiratory infections on lung development and childhood asthma. J. Allergy Clin. Immunol. 2005, 115:668-674. quiz 675.
147. Wright J.R. Immunoregulatory functions of surfactant proteins. Nat. Rev. Immunol. 2005, 5:58-68.
148. Marin L., Dufour M.E., Tordet C., Nguyen M. 1,25(OH)2D3 stimulates phospholipid biosynthesis and surfactant release in fetal rat lung explants. Biol. Neonate. 1990, 57:257-260.
149. Nguyen T.M., Guillozo H., Marin L., Tordet C., Koite S., Garabedian M. Evidence for a vitamin D paracrine system regulating maturation of developing rat lung epithelium. Am. J. Physiol. 1996, 271:L392-399.
150. Phokela S.S., Peleg S., Moya F.R., Alcorn J.L. Regulation of human pulmonary surfactant protein gene expression by 1alpha,25-dihydroxyvitamin D3. Am. J. Physiol. Lung Cell Mol. Physiol. 2005, 289:L617-626.
151. Burri P.H., Dbaly J., Weibel E.R. The postnatal growth of the rat lung. I. Morphometry. Anat. Rec. 1974, 178:711-730.
152. Awonusonu F., Srinivasan S., Strange J., Al-Jumaily W., Bruce M.C. Developmental shift in the relative percentages of lung fibroblast subsets: role of apoptosis postseptation. Am. J. Physiol. 1999, 277:L848-859.
153. Sakurai R., Shin E., Fonseca S., Sakurai T., Litonjua A.A., Weiss S.T., et al. 1Alpha,25(OH)2D3 and its 3-epimer promote rat lung alveolar epithelial-mesenchymal interactions and inhibit lipofibroblast apoptosis. Am. J. Physiol. Lung Cell Mol. Physiol. 2009, 297:L496-505.
154. Nadeau K., Montermini L., Mandeville I., Xu M., Weiss S.T., Sweezey N.B., Kaplan F. Modulation of Lgl1 by steroid, retinoic acid, and vitamin D models complex transcriptional regulation during alveolarization. Pediatr Res. 2010, 67:375-381.
155. Gombart A.F., Borregaard N., Koeffler H.P. Human cathelicidin antimicrobial peptide (CAMP) gene is a direct target of the vitamin D receptor and is strongly up-regulated in myeloid cells by 1,25-dihydroxyvitamin D3. FASEB J. 2005, 19:1067-1077.
156. Liu P.T., Stenger S., Li H., Wenzel L., Tan B.H., Krutzik S.R., et al. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 2006, 311:1770-1773.
157. Liu P.T., Stenger S., Tang D.H., Modlin R.L. Cutting edge: vitamin D-mediated human antimicrobial activity against Mycobacterium tuberculosis is dependent on the induction of cathelicidin. J. Immunol. 2007, 179:2060-2063.
158. Yim S., Dhawan P., Ragunath C., Christakos S., Diamond G. Induction of cathelicidin in normal and CF bronchial epithelial cells by 1,25-dihydroxyvitamin D(3). J. Cyst. Fibros. 2007, 6:403-410.
159. Hiemstra P.S. The role of epithelial beta-defensins and cathelicidins in host defense of the lung. Exp. Lung Res. 2007, 33:537-542.
160. Weber G., Heilborn J.D., Chamorro Jimenez C.I., Hammarsjo A., Torma H., Stahle M. Vitamin D induces the antimicrobial protein hCAP18 in human skin. J. Invest. Dermatol. 2005, 124:1080-1082.
161. Levy O. Innate immunity of the newborn: basic mechanisms and clinical correlates. Nat. Rev. Immunol. 2007, 7:379-390.
162. Griffin M.D., Xing N., Kumar R. Vitamin D and its analogs as regulators of immune activation and antigen presentation. Annu. Rev. Nutr. 2003, 23:117-145.
163. Lin R., White J.H. The pleiotropic actions of vitamin D. Bioessays 2004, 26:21-28.
164. Gregori S., Giarratana N., Smiroldo S., Uskokovic M., Adorini L. A 1alpha,25-dihydroxyvitamin D(3) analog enhances regulatory T-cells and arrests autoimmune diabetes in NOD mice. Diabetes 2002, 51:1367-1374.
165. Meehan M.A., Kerman R.H., Lemire J.M. 1,25-Dihydroxyvitamin D3 enhances the generation of nonspecific suppressor cells while inhibiting the induction of cytotoxic cells in a human MLR. Cell Immunol. 1992, 140:400-409.
166. Schwartz R.H. Natural regulatory T cells and self-tolerance. Nat. Immunol. 2005, 6:327-330.
167. Matheu V., Back O., Mondoc E., Issazadeh-Navikas S. Dual effects of vitamin D-induced alteration of TH1/TH2 cytokine expression: enhancing IgE production and decreasing airway eosinophilia in murine allergic airway disease. J. Allergy. Clin. Immunol. 2003, 112:585-592.
168. Cantorna M.T., Zhu Y., Froicu M., Wittke A. Vitamin D status, 1,25-dihydroxyvitamin D3, and the immune system. Am. J. Clin. Nutr. 2004, 80:1717S-1720S.
169. Pichler J., Gerstmayr M., Szepfalusi Z., Urbanek R., Peterlik M., Willheim M. 1 Alpha,25(OH)2D3 inhibits not only Th1 but also Th2 differentiation in human cord blood T cells. Pediatr. Res. 2002, 52:12-18.
170. Xystrakis E., Urry Z., Hawrylowicz C.M. Regulatory T cell therapy as individualized medicine for asthma and allergy. Curr. Opin. Allergy Clin. Immunol. 2007, 7:535-541.
171. Annesi-Maesano I. Perinatal events, vitamin D, and the development of allergy. Pediatr. Res. 2002, 52:3-5.
172. Sampson H.A., Munoz-Furlong A., Campbell R.L., Adkinson N.F., Bock S.A., Branum A., et al. Second symposium on the definition and management of anaphylaxis: summary report-second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium. Ann. Emerg. Med. 2006, 47:373-380.
173. Hong S.P., Kim M.J., Jung M.Y., Jeon H., Goo J., Ahn S.K., et al. Biopositive effects of low-dose UVB on epidermis: coordinate upregulation of antimicrobial peptides and permeability barrier reinforcement. J. Invest. Dermatol. 2008, 128:2880-2887.
174. Vahavihu K., Ala-Houhala M., Peric M., Karisola P., Kautiainen H., Hasan T., et al. Narrowband ultraviolet B treatment improves vitamin D balance and alters antimicrobial peptide expression in skin lesions of psoriasis and atopic dermatitis. Br. J. Dermatol. 2010, 163:321-328.
175. Hata T.R., Kotol P., Jackson M., Nguyen M., Paik A., Udall D., et al. Administration of oral vitamin D induces cathelicidin production in atopic individuals. J. Allergy Clin. Immunol. 2008, 122:829-831.
176. Weiland S.K., Husing A., Strachan D.P., Rzehak P., Pearce N. Climate and the prevalence of symptoms of asthma, allergic rhinitis, and atopic eczema in children. Occup. Environ. Med. 2004, 61:609-615.
177. Staples J.A., Ponsonby A.L., Lim L.L., McMichael A.J. Ecologic analysis of some immune-related disorders, including type 1 diabetes, in Australia: latitude, regional ultraviolet radiation, and disease prevalence. Environ. Health Perspect. 2003, 111:518-523.
178. Oren E., Banerji A., Camargo C.A. Vitamin D and atopic disorders in an obese population screened for vitamin D deficiency. J. Allergy Clin. Immunol. 2008, 121:533-534.
179. Sidbury R., Sullivan A.F., Thadhani R.I., Camargo C.A. Randomized controlled trial of vitamin D supplementation for winter-related atopic dermatitis in Boston: a pilot study. Br. J. Dermatol. 2008, 159:245-247.
180. B Khandsuren, D Ganmaa, R Sidbury, K Erdenedelger, N Radnaakhand, CA Camargo, Jr. 2009 Randomized controlled trial of vitamin D supplementation for winter-related atopic dermatitis in Mongolian children [abstract]. In: World Congress of Pediatric Dermatology. Bangkok, Thailand.
181. Byremo G., Rod G., Carlsen K.H. Effect of climatic change in children with atopic eczema. Allergy 2006, 61:1403-1410.
182. Wjst M., Hypponen E. Vitamin D serum levels and allergic rhinitis. Allergy 2007, 62:1085-1086.
183. Camargo C.A., Clark S., Kaplan M.S., Lieberman P., Wood R.A. Regional differences in EpiPen prescriptions in the United States: the potential role of vitamin D. J. Allergy Clin. Immunol. 2007, 120:131-136.
184. Camargo C.A., Clark S., Pearson J.F., Kaplan M.S., Lieberman P., Wood R.A. Latitude, UVB exposure, and EpiPen prescriptions in 38 urban areas [abstract]. J. Allergy Clin. Immunol. 2009, 123(Suppl.):S109.
185. Mullins R.J., Clark S., Camargo C.A. Regional variation in epinephrine autoinjector prescriptions in Australia: more evidence for the vitamin D-anaphylaxis hypothesis. Ann. Allergy Asthma Immunol. 2009, 103:488-495.
186. Simons F.E., Peterson S., Black C.D. Epinephrine dispensing patterns for an out-of-hospital population: a novel approach to studying the epidemiology of anaphylaxis. J. Allergy Clin. Immunol. 2002, 110:647-651.
187. Sheehan W.J., Graham D., Ma L., Baxi S., Phipatanakul W. Higher incidence of pediatric anaphylaxis in northern areas of the United States. J. Allergy Clin. Immunol. 2009, 124:850-852. e852.
188. Rudders S.A., Espinola J.A., Camargo C.A. North-south differences in US emergency department visits for acute allergic reactions. Ann. Allergy Asthma Immunol. 2010, 104:413-416.
189. Mullins R.J., Clark S., Camargo C.A. Regional variation in infant hypoallergenic formula prescriptions in Australia. Pediatr. Allergy Immunol. 2010, 21:e413-420.
190. Schauber J., Gallo R.L. Antimicrobial peptides and the skin immune defense system. J. Allergy Clin. Immunol. 2008, 122:261-266.
191. Vassallo M.F., Camargo C.A. Potential mechanisms for the hypothesized link between sunshine, vitamin D, and food allergy in children. J. Allergy Clin. Immunol. 2010, 126:217-222.
192. Scragg R., Camargo C.A. Frequency of leisure-time physical activity and serum 25-hydroxyvitamin D levels in the US population: results from the Third National Health and Nutrition Examination Survey. Am. J. Epidemiol. 2008, 168:577-586. discussion 587-591.
193. Bosse Y., Maghni K., Hudson T.J. 1Alpha,25-dihydroxy-vitamin D3 stimulation of bronchial smooth muscle cells induces autocrine, contractility, and remodeling processes. Physiol. Genomics 2007, 29:161-168.
194. Banerjee A., Damera G., Bhandare R., Gu S., Lopez-Boado Y., Panettieri R., et al. Vitamin D and glucocorticoids differentially modulate chemokine expression in human airway smooth muscle cells. Br. J. Pharmacol. 2008, 155:84-92.
195. Damera G., Fogle H.W., Lim P., Goncharova E.A., Zhao H., Banerjee A., et al. Vitamin D inhibits growth of human airway smooth muscle cells through growth factor-induced phosphorylation of retinoblastoma protein and checkpoint kinase 1. Br. J. Pharmacol. 2009, 158:1429-1441.
196. Institute of Medicine Food and Nutrition Board DRI: Dietary Reference Intakes for Calcium, Phosphorus, Magnesium, Vitamin D, and Fluoride 1997, National Academies Press, Washington, DC.
197. Bischoff-Ferrari H.A., Giovannucci E., Willett W.C., Dietrich T., Dawson-Hughes B. Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am. J. Clin. Nutr. 2006, 84:18-28.
198. Bischoff-Ferrari H.A., Shao A., Dawson-Hughes B., Hathcock J., Giovannucci E., Willett W.C. Benefit-risk assessment of vitamin D supplementation. Osteoporos. Int. 2010, 21:1121-1132.
199. Barger-Lux M.J., Heaney R.P., Dowell S., Chen T.C., Holick M.F. Vitamin D and its major metabolites: serum levels after graded oral dosing in healthy men. Osteoporos. Int. 1998, 8:222-230.
200. Green D., Carson K., Leonard A., Davis J.E., Rosenstein B., Zeitlin P., et al. Current treatment recommendations for correcting vitamin D deficiency in pediatric patients with cystic fibrosis are inadequate. J. Pediatr. 2008, 153:554-559.
201. Hall W.B., Sparks A.A., Aris R.M. Vitamin D deficiency in cystic fibrosis. Int. J. Endocrinol. 2010, 2010:218691.
202. Stein R.T., Holberg C.J., Morgan W.J., Wright A.L., Lombardi E., Taussig L., et al. Peak flow variability, methacholine responsiveness and atopy as markers for detecting different wheezing phenotypes in childhood. Thorax 1997, 52:946-952.
203. Legg J.P., Warner J.A., Johnston S.L., Warner J.O. Frequency of detection of picornaviruses and seven other respiratory pathogens in infants. Pediatr. Infect. Dis. J. 2005, 24:611-616.
204. Kusel M.M., de Klerk N.H., Kebadze T., Vohma V., Holt P.G., Johnston S.L., et al. Early-life respiratory viral infections, atopic sensitization, and risk of subsequent development of persistent asthma. J. Allergy Clin. Immunol. 2007, 119:1105-1110.
205. Mansbach J.M., McAdam A.J., Clark S., Hain P.D., Flood R.G., Acholonu U., et al. Prospective multicenter study of the viral etiology of bronchiolitis in the emergency department. Acad. Emerg. Med. 2008, 15:111-118.